The single most extensively researched cellular bioenergetic compound in human history, proven to enhance cerebral cognition, skeletal muscular power, bone density, and cellular methylation sparing.
Creatine Monohydrate
The single most extensively researched cellular bioenergetic compound in human history, proven to enhance cerebral cognition, skeletal muscular power, bone density, and cellular methylation sparing.
The single most extensively researched cellular bioenergetic compound in human history, proven to enhance cerebral cognition, skeletal muscular power, bone density, and cellular methylation sparing.
Optimal dose-response curve and long-term human trial replication remain under ongoing investigation.
Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance: a systematic review and meta-analysis
“Creatine monohydrate combined with resistance training yields an average 20% increase in maximal muscular strength and accelerates cellular phosphocreatine ATP resynthesis.”
Safety Boundary & Dosing Considerations
“Individual variation in bioavailability and optimal dosing thresholds.”
Scientific Dual-Coverage Profile
Standardized evaluation across 8 Systemic Longevity Vectors and 12 Hallmarks of Aging.
Heart & Cardiovascular
Synergistic Target (30-64)Replenishes myocardial phosphocreatine reserves, improving stroke work efficiency during hemodynamic demands.
Brain Longevity & Cognition
Foundational Target (65-100)Traverses the blood-brain barrier to replenish neuronal phosphocreatine buffers, protecting ATP synthesis during acute sleep deprivation and cognitively demanding tasks.
Metabolic & Glycemic Health
Synergistic Target (30-64)Augments cellular hydration and skeletal muscle glycogen re-synthesis, stimulating AMPK-independent GLUT4 translocation.
Cancer Defense & Autophagy
Marginal Impact (5-29)Recent evidence shows creatine uptake directly fuels cytotoxic CD8+ T lymphocytes, sustaining antitumor effector activity in metabolic starvation microenvironments.
Endocrine Vitality & Anabolic Tone
Synergistic Target (30-64)Supports increased training volume and mechanical load during resistance exercise, indirectly promoting post-exercise hormonal release.
Systemic Inflammation Suppression
Synergistic Target (30-64)Attenuates exercise-induced membrane micro-ruptures and suppresses oxidative burst from infiltrating neutrophils post-heavy resistance loading.
Bone Density & Connective Matrix
Synergistic Target (30-64)Enables greater skeletal mechanotransductive loading during axial resistance training, stimulating osteoblast activity and slowing osteoporotic bone loss.
Cellular Longevity & Epigenetics
Foundational Target (65-100)Exogenous creatine spares up to 40% of the body daily S-adenosylmethionine (SAMe) methyl pool that would otherwise be consumed in guanidinoacetate methylation, freeing methyl groups for DNA and histone methylation.
Functional Outcomes & Performance Impact
Calibrated clinical effect sizes (0–99 scale) for practical daily goals beyond pure longevity — including physical strength, cognitive focus, restorative sleep, and metabolic resilience.
Strength
daily wellbeingClinical Endpoint: +8% greater increase in maximal 1RM strength and +14% repetitions to failure across 22 randomized trials.
Overall Energy
daily wellbeingClinical Endpoint: +9.2% increase in prefrontal cortex phosphocreatine (PCr) reserves via 31P-MRS and +19% working memory accuracy under sleep deprivation.
Recovery
Clinical Endpoint: +1.4 kg greater appendicular lean mass gain and preservation of femoral neck bone mineral density (p = 0.040).
Focus
daily wellbeingClinical Endpoint: Statistically significant improvements in short-term working memory retrieval speed (p = 0.003) and fluid intelligence reasoning.
Bone Matrix Health
Clinical Endpoint: +3.4% greater bone mineral density preservation at the proximal femur compared to placebo training.
Score Breakdown: 96 / 100
Study design hierarchy (RCT > Cohort > Rodent > In Vitro), journal impact factor, sample power.
Shift in clinically validated biomarkers (VO2 Max, ApoB, Fasting Insulin, hs-CRP, Epigenetic Clocks).
Adverse event frequency, toxicology window, long-term organ tolerability.
Multi-system pleiotropy across the 8 canonical longevity vectors.
Affordability, time burden, friction to sustained daily/weekly compliance.
Practicality, Cost & Adherence Index
Creatine Monohydrate Multi-Trial Scientific Evidence
Transparent catalog of peer-reviewed human clinical trials and landmark animal cohorts with exact biomarker deltas, sample sizes, and risk-of-bias evaluations.
Creatine Supplementation and Brain Health: Bioenergetics, Cognitive Performance, and Neuroprotection
Effects of Creatine Supplementation on Cognitive Function of Healthy Individuals: A Systematic Review of Randomized Controlled Trials
Effect of Creatine Supplementation During Resistance Training on Bone Mineral Density and Muscle Mass in Older Adults: A Meta-Analysis
Creatine in Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
Methylation Demand and Homocysteine Metabolism: Effects of Dietary Creatine
Creatine Monohydrate Evidence Timeline
Initial Mechanistic Validation
Early molecular characterization demonstrates direct modulation of cellular stress pathways.
Controlled Human Pilot Trial
Demonstrated statistically significant shifts in primary biomarkers without dose-limiting adverse events.
Creatine Monohydrate Safety Matrix
Absolute Contraindications (Do Not Use)
- •Pre-existing end-stage renal disease (ESRD) or severe chronic kidney disease requiring dialysis (note: creatine raises benign serum creatinine biomarker without harming GFR)
Pharmacological & Supplement Interactions
Insulin-mediated sodium-dependent creatine transporter (CreaT) activation enhances skeletal muscle creatine uptake by up to 20%.
Concurrent chronic high-dose NSAID abuse may compound renal hemodynamic stress in dehydrated states.
Proven Adverse Effects vs. Theoretical Risks
- •Benign intracellular water retention in skeletal muscle (1-2 kg initial weight gain)
- •Mild transient stomach discomfort if consumed in large single boluses (>10g) without adequate water
- •None identified across decades of continuous human clinical trials up to 30g/day
Under-Researched Populations (Evidence Gaps)
Clinical longevity literature disproportionately studies middle-aged male or rodent models. Exercise caution in:
- Very few - thoroughly researched in infants with guanidinoacetate methyltransferase deficiency through nonagenarians
Biological Relationship Graph
Combines safely with baseline longevity routines.
No direct clinical antagonisms detected.
Validated Commercial Formulations
Creatine Monohydrate (Creapure®)
100% pure Creapure synthesized in Germany with negligible dicyandiamide impurities.